These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 7537651)
1. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [TBL] [Abstract][Full Text] [Related]
2. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936 [TBL] [Abstract][Full Text] [Related]
4. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727 [TBL] [Abstract][Full Text] [Related]
6. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
7. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. Ławicki S; Mroczko B; Szmitkowski M Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma. Putzki H; Student A; Jablonski M; Heymann H Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817 [TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents. Angel CA; Pratt CB; Rao BN; Schell MJ; Parham DM; Lobe TE; Fleming ID Cancer; 1992 Mar; 69(6):1487-91. PubMed ID: 1311626 [TBL] [Abstract][Full Text] [Related]
10. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related]
11. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859 [TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding. Cosimelli M; De Peppo F; Castelli M; Giannarelli D; Schinaia G; Castaldo P; Buttini GL; Sciarretta F; Bigotti G; Di Filippo F Dis Colon Rectum; 1989 May; 32(5):389-97. PubMed ID: 2714130 [TBL] [Abstract][Full Text] [Related]
13. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen. Carpelan-Holmström MA; Haglund CH; Roberts PJ Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374 [TBL] [Abstract][Full Text] [Related]
14. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer. Barillari P; Bolognese A; Chirletti P; Cardi M; Sammartino P; Stipa V Dis Colon Rectum; 1992 May; 35(5):471-6. PubMed ID: 1568399 [TBL] [Abstract][Full Text] [Related]
15. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. Inoue M; Fujita M; Nakazawa A; Ogawa H; Tanizawa O Obstet Gynecol; 1992 Mar; 79(3):434-40. PubMed ID: 1346716 [TBL] [Abstract][Full Text] [Related]
16. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma? Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG Oncology; 1989; 46(6):381-5. PubMed ID: 2479897 [TBL] [Abstract][Full Text] [Related]
17. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628 [TBL] [Abstract][Full Text] [Related]
18. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage. Ståhle E; Glimelius B; Bergström R; Påhlman L Eur J Surg Oncol; 1988 Aug; 14(4):277-86. PubMed ID: 3165869 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of skeletal metastases by serum tumor markers]. Shinozaki T; Chigira M Nihon Seikeigeka Gakkai Zasshi; 1991 Aug; 65(8):441-6. PubMed ID: 1720162 [TBL] [Abstract][Full Text] [Related]
20. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]